LoginCreate an account

  Username: Password:
 
Error
  • Error loading feed data.
Home

FDA probes heart problems with asthma drug Xolair

E-mail Print PDF
User Rating: / 0
PoorBest 

WASHINGTON (AP) ‚  Federal regulators are reviewing data that suggest the asthma medication Xolair can cause heart attacks, strokes and other potentially deadly problems.

The Food and Drug Administration says preliminary results from a study of 5,000 patients taking the drug suggests an increased risk of heart problems and stroke. The drug's manufacturer Genentech, a unit of Swiss pharmaceutical giant Roche, designed the study to track the long-term safety of the drug over five years.

A representative for Genentech says final results are not expected until 2012. The South San Francisco-based company says it will continue gathering safety information about Xolair.

The FDA says patients should continue taking the drug as directed.


Copyright 2009 The Associated Press.

 

 

 
FOX News
FOXNews.com - Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
FOX News
  • New blood pressure guidelines not one-size-fits-all
    Finding the right blood pressure may not be so straightforward, with new guidelines tackling a controversial question for many older adults on blood pressure medications: How low should you go?
  • Teen with terminal cancer has one final request: Be kind
    Seventeen-year-old Rebecca Schofield has three months to a year to live, doctors say. The bold Canadian teen in Riverview, New Brunswick, has cancer, and a final request.
  • Skin cancer cream could kill your pet, FDA warns
    The Food and Drug Administration warned pet owners Wednesday that dogs, cats and other animals may die if exposed to skin cancer creams. It may be sold under the names Carac, Efudex and Fluoroplex, all of which contain the active ingredient fluorouracil, also known as 5-FU, and it may be a danger to pets.

Search...

WebSite

mySSnews Login



User Menu